US Stock MarketDetailed Quotes

MRNS Marinus Pharmaceuticals

Watchlist
  • 1.430
  • +0.040+2.88%
Close Jul 19 16:00 ET
  • 1.439
  • +0.009+0.64%
Post 19:38 ET
78.56MMarket Cap-541P/E (TTM)

Marinus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-26.02%7.68M
21.63%30.99M
0.39%7.19M
213.59%7.34M
239.72%6.08M
-26.83%10.38M
66.03%25.48M
371.18%7.16M
-76.86%2.34M
-6.04%1.79M
Operating revenue
-26.02%7.68M
21.63%30.99M
0.39%7.19M
213.59%7.34M
239.72%6.08M
-26.83%10.38M
66.03%25.48M
371.18%7.16M
-76.86%2.34M
-6.04%1.79M
Cost of revenue
266.99%756K
468.82%1.93M
203.77%887K
847.92%455K
386K
206K
-77.00%340K
292K
-96.75%48K
0
Gross profit
-31.95%6.92M
15.58%29.06M
-8.25%6.3M
200.31%6.88M
218.16%5.7M
-28.28%10.17M
81.28%25.14M
351.97%6.87M
-73.46%2.29M
1.79M
Operating expense
-0.91%42.74M
16.40%160.54M
15.68%41.74M
18.95%38.53M
-3.69%37.13M
39.62%43.14M
24.48%137.93M
26.00%36.08M
16.49%32.39M
51.86%38.56M
Selling and administrative expenses
22.51%18.63M
7.58%61.15M
4.78%15.36M
11.05%14.87M
-7.85%15.72M
29.54%15.2M
52.49%56.85M
38.00%14.66M
41.65%13.39M
149.87%17.06M
Research and development costs
-13.66%24.12M
24.37%99.39M
23.14%26.38M
24.52%23.66M
-0.39%21.41M
55.26%27.93M
8.69%79.91M
18.93%21.42M
3.54%19M
15.80%21.5M
Other operating expenses
----
----
----
----
----
----
--1.17M
--0
----
----
Operating profit
-8.67%-35.82M
-16.58%-131.49M
-21.31%-35.44M
-5.14%-31.65M
14.49%-31.44M
-97.25%-32.96M
-16.36%-112.79M
-7.73%-29.21M
-57.02%-30.1M
-56.55%-36.77M
Net non-operating interest income expense
-59.87%-2.88M
-5.58%-8.78M
-31.09%-2.55M
-10.71%-2.35M
19.13%-2.08M
-7.38%-1.8M
-232.45%-8.32M
-27.19%-1.95M
-220.73%-2.12M
-667.76%-2.57M
Non-operating interest income
-37.60%1.46M
244.65%8.11M
0.17%1.75M
268.68%1.9M
2,433.33%2.13M
19,425.00%2.34M
2,842.50%2.35M
7,482.61%1.74M
2,923.53%514K
425.00%84K
Non-operating interest expense
4.80%4.35M
58.31%16.9M
16.48%4.3M
61.05%4.24M
58.43%4.21M
145.09%4.15M
313.32%10.67M
137.60%3.69M
288.50%2.63M
656.70%2.66M
Other net income (expense)
-2.70%36K
-102.56%-2.68M
-149.24%-3.78M
-99.05%1.02M
149.47%47K
103.81%37K
15,832.88%104.68M
-544.87%-1.52M
33,107.74%107.26M
-3,066.67%-95K
Other non- operating income (expenses)
-2.70%36K
-102.56%-2.68M
-149.24%-3.78M
-99.05%1.02M
149.47%47K
103.81%37K
15,832.88%104.68M
-544.87%-1.52M
33,107.74%107.26M
-3,066.67%-95K
Income before tax
-11.34%-38.67M
-770.17%-142.94M
-27.83%-41.77M
-143.94%-32.97M
15.12%-33.47M
-79.38%-34.73M
83.37%-16.43M
-15.44%-32.68M
484.69%75.04M
-65.52%-39.43M
Income tax
-145.38%-1.54M
0
0
-1.54M
3.39M
1.64M
1.75M
0
Net income
-11.34%-38.67M
-613.59%-141.41M
-21.73%-41.77M
-144.99%-32.97M
19.02%-31.93M
-79.38%-34.73M
79.94%-19.82M
-21.22%-34.31M
475.71%73.29M
-65.52%-39.43M
Net income continuous Operations
-11.34%-38.67M
-613.59%-141.41M
-21.73%-41.77M
-144.99%-32.97M
19.02%-31.93M
-79.38%-34.73M
79.94%-19.82M
-21.22%-34.31M
475.71%73.29M
-65.52%-39.43M
Minority interest income
Net income attributable to the parent company
-11.34%-38.67M
-613.59%-141.41M
-21.73%-41.77M
-144.99%-32.97M
19.02%-31.93M
-79.38%-34.73M
79.94%-19.82M
-21.22%-34.31M
475.71%73.29M
-65.52%-39.43M
Preferred stock dividends
1.66M
Other preferred stock dividends
Net income attributable to common stockholders
-11.34%-38.67M
-613.59%-141.41M
-22.94%-41.77M
-146.03%-32.97M
19.02%-31.93M
-79.38%-34.73M
79.94%-19.82M
-20.04%-33.98M
467.22%71.63M
-65.52%-39.43M
Basic earnings per share
-1.49%-0.68
-415.69%-2.63
2.63%-0.74
-131.61%-0.61
42.45%-0.61
-28.85%-0.67
81.04%-0.51
1.30%-0.76
464.15%1.93
-63.08%-1.06
Diluted earnings per share
-1.49%-0.68
-415.69%-2.63
2.63%-0.74
-132.28%-0.61
42.45%-0.61
-28.85%-0.67
81.04%-0.51
1.30%-0.76
456.60%1.89
-63.08%-1.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -26.02%7.68M21.63%30.99M0.39%7.19M213.59%7.34M239.72%6.08M-26.83%10.38M66.03%25.48M371.18%7.16M-76.86%2.34M-6.04%1.79M
Operating revenue -26.02%7.68M21.63%30.99M0.39%7.19M213.59%7.34M239.72%6.08M-26.83%10.38M66.03%25.48M371.18%7.16M-76.86%2.34M-6.04%1.79M
Cost of revenue 266.99%756K468.82%1.93M203.77%887K847.92%455K386K206K-77.00%340K292K-96.75%48K0
Gross profit -31.95%6.92M15.58%29.06M-8.25%6.3M200.31%6.88M218.16%5.7M-28.28%10.17M81.28%25.14M351.97%6.87M-73.46%2.29M1.79M
Operating expense -0.91%42.74M16.40%160.54M15.68%41.74M18.95%38.53M-3.69%37.13M39.62%43.14M24.48%137.93M26.00%36.08M16.49%32.39M51.86%38.56M
Selling and administrative expenses 22.51%18.63M7.58%61.15M4.78%15.36M11.05%14.87M-7.85%15.72M29.54%15.2M52.49%56.85M38.00%14.66M41.65%13.39M149.87%17.06M
Research and development costs -13.66%24.12M24.37%99.39M23.14%26.38M24.52%23.66M-0.39%21.41M55.26%27.93M8.69%79.91M18.93%21.42M3.54%19M15.80%21.5M
Other operating expenses --------------------------1.17M--0--------
Operating profit -8.67%-35.82M-16.58%-131.49M-21.31%-35.44M-5.14%-31.65M14.49%-31.44M-97.25%-32.96M-16.36%-112.79M-7.73%-29.21M-57.02%-30.1M-56.55%-36.77M
Net non-operating interest income expense -59.87%-2.88M-5.58%-8.78M-31.09%-2.55M-10.71%-2.35M19.13%-2.08M-7.38%-1.8M-232.45%-8.32M-27.19%-1.95M-220.73%-2.12M-667.76%-2.57M
Non-operating interest income -37.60%1.46M244.65%8.11M0.17%1.75M268.68%1.9M2,433.33%2.13M19,425.00%2.34M2,842.50%2.35M7,482.61%1.74M2,923.53%514K425.00%84K
Non-operating interest expense 4.80%4.35M58.31%16.9M16.48%4.3M61.05%4.24M58.43%4.21M145.09%4.15M313.32%10.67M137.60%3.69M288.50%2.63M656.70%2.66M
Other net income (expense) -2.70%36K-102.56%-2.68M-149.24%-3.78M-99.05%1.02M149.47%47K103.81%37K15,832.88%104.68M-544.87%-1.52M33,107.74%107.26M-3,066.67%-95K
Other non- operating income (expenses) -2.70%36K-102.56%-2.68M-149.24%-3.78M-99.05%1.02M149.47%47K103.81%37K15,832.88%104.68M-544.87%-1.52M33,107.74%107.26M-3,066.67%-95K
Income before tax -11.34%-38.67M-770.17%-142.94M-27.83%-41.77M-143.94%-32.97M15.12%-33.47M-79.38%-34.73M83.37%-16.43M-15.44%-32.68M484.69%75.04M-65.52%-39.43M
Income tax -145.38%-1.54M00-1.54M3.39M1.64M1.75M0
Net income -11.34%-38.67M-613.59%-141.41M-21.73%-41.77M-144.99%-32.97M19.02%-31.93M-79.38%-34.73M79.94%-19.82M-21.22%-34.31M475.71%73.29M-65.52%-39.43M
Net income continuous Operations -11.34%-38.67M-613.59%-141.41M-21.73%-41.77M-144.99%-32.97M19.02%-31.93M-79.38%-34.73M79.94%-19.82M-21.22%-34.31M475.71%73.29M-65.52%-39.43M
Minority interest income
Net income attributable to the parent company -11.34%-38.67M-613.59%-141.41M-21.73%-41.77M-144.99%-32.97M19.02%-31.93M-79.38%-34.73M79.94%-19.82M-21.22%-34.31M475.71%73.29M-65.52%-39.43M
Preferred stock dividends 1.66M
Other preferred stock dividends
Net income attributable to common stockholders -11.34%-38.67M-613.59%-141.41M-22.94%-41.77M-146.03%-32.97M19.02%-31.93M-79.38%-34.73M79.94%-19.82M-20.04%-33.98M467.22%71.63M-65.52%-39.43M
Basic earnings per share -1.49%-0.68-415.69%-2.632.63%-0.74-131.61%-0.6142.45%-0.61-28.85%-0.6781.04%-0.511.30%-0.76464.15%1.93-63.08%-1.06
Diluted earnings per share -1.49%-0.68-415.69%-2.632.63%-0.74-132.28%-0.6142.45%-0.61-28.85%-0.6781.04%-0.511.30%-0.76456.60%1.89-63.08%-1.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg